CARDIALYTICS™ AI Suite
Atrial Fibrillation / Complex Atrial Arrhythmia
Pre-clinicalActive
Key Facts
Indication
Atrial Fibrillation / Complex Atrial Arrhythmia
Phase
Pre-clinical
Status
Active
Company
About CathVision
CathVision is a Copenhagen-based private company, founded in 2010, that is commercializing the ECGenius™ System, an FDA-cleared EP recording platform designed to acquire high-fidelity cardiac electrical signals. The company is augmenting this hardware with its CARDIALYTICS™ suite of AI-based analytic tools for automated, real-time analysis during procedures like atrial fibrillation ablation. By addressing the limitations of traditional, noisy EP recording systems, CathVision aims to become a new standard in the EP lab, integrating advanced signal acquisition with decision-support software.
View full company profile